195 related articles for article (PubMed ID: 12393520)
1. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.
Zhan F; Tian E; Bumm K; Smith R; Barlogie B; Shaughnessy J
Blood; 2003 Feb; 101(3):1128-40. PubMed ID: 12393520
[TBL] [Abstract][Full Text] [Related]
2. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.
Zhan F; Hardin J; Kordsmeier B; Bumm K; Zheng M; Tian E; Sanderson R; Yang Y; Wilson C; Zangari M; Anaissie E; Morris C; Muwalla F; van Rhee F; Fassas A; Crowley J; Tricot G; Barlogie B; Shaughnessy J
Blood; 2002 Mar; 99(5):1745-57. PubMed ID: 11861292
[TBL] [Abstract][Full Text] [Related]
3. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression.
Medina F; Segundo C; Campos-Caro A; González-García I; Brieva JA
Blood; 2002 Mar; 99(6):2154-61. PubMed ID: 11877292
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
5. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
[TBL] [Abstract][Full Text] [Related]
6. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes modulated in multiple myeloma using genetically identical twin samples.
Munshi NC; Hideshima T; Carrasco D; Shammas M; Auclair D; Davies F; Mitsiades N; Mitsiades C; Kim RS; Li C; Rajkumar SV; Fonseca R; Bergsagel L; Chauhan D; Anderson KC
Blood; 2004 Mar; 103(5):1799-806. PubMed ID: 12969976
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
9. Early preplasma cells define a tolerance checkpoint for autoreactive B cells.
Culton DA; O'Conner BP; Conway KL; Diz R; Rutan J; Vilen BJ; Clarke SH
J Immunol; 2006 Jan; 176(2):790-802. PubMed ID: 16393962
[TBL] [Abstract][Full Text] [Related]
10. The molecular classification of multiple myeloma.
Zhan F; Huang Y; Colla S; Stewart JP; Hanamura I; Gupta S; Epstein J; Yaccoby S; Sawyer J; Burington B; Anaissie E; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Walker R; Zangari M; Crowley J; Barlogie B; Shaughnessy JD
Blood; 2006 Sep; 108(6):2020-8. PubMed ID: 16728703
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
12. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
[TBL] [Abstract][Full Text] [Related]
13. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
14. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
15. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization.
Jourdan M; Caraux A; De Vos J; Fiol G; Larroque M; Cognot C; Bret C; Duperray C; Hose D; Klein B
Blood; 2009 Dec; 114(25):5173-81. PubMed ID: 19846886
[TBL] [Abstract][Full Text] [Related]
16. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Yaccoby S
Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.
Pellat-Deceunynck C; Bataille R; Robillard N; Harousseau JL; Rapp MJ; Juge-Morineau N; Wijdenes J; Amiot M
Blood; 1994 Oct; 84(8):2597-603. PubMed ID: 7522634
[TBL] [Abstract][Full Text] [Related]
18. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.
Wijdenes J; Vooijs WC; Clément C; Post J; Morard F; Vita N; Laurent P; Sun RX; Klein B; Dore JM
Br J Haematol; 1996 Aug; 94(2):318-23. PubMed ID: 8759892
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
[TBL] [Abstract][Full Text] [Related]
20. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts.
Tarte K; De Vos J; Thykjaer T; Zhan F; Fiol G; Costes V; Rème T; Legouffe E; Rossi JF; Shaughnessy J; Ørntoft TF; Klein B
Blood; 2002 Aug; 100(4):1113-22. PubMed ID: 12149187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]